Condition
Polysubstance Addiction
Total Trials
3
Recruiting
1
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Not Yet Recruiting1
Recruiting1
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT05973838Not ApplicableRecruitingPrimary
Peer Recovery to Improve Polysubstance Use and Mobile Telemedicine Retention
NCT07161986Not ApplicableCompleted
Mapping And Preventing Relapse Risk in Polydrug Users
NCT06211972Not ApplicableNot Yet Recruiting
The Feasibility of the OpiVenture Program for Clients Undergoing Opioid Agonist Therapy
Showing all 3 trials